Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs
Our results confirm that cell surface NCL is a biomarker and a potential target for NB, paving the way for further investigations aimed at the future clinical translation of innovative combination strategies against NB.
Authors
- Eleonora Ciampi (ORCID: https://orcid.org/0009-0003-5044-3184)
- Mirco Ponzoni (ORCID: https://orcid.org/0000-0002-6164-4286)
- Vito Alessandro Lasorsa (ORCID: https://orcid.org/0000-0002-9552-7192)
- Barbara Gualco
- Giovanna Bianchi (ORCID: https://orcid.org/0000-0002-0888-3616)
- Martina Morini (ORCID: https://orcid.org/0000-0003-2569-4515)
- Gabriele Gaggero (ORCID: https://orcid.org/0000-0001-9098-563X)
- Michele Cilli (ORCID: https://orcid.org/0000-0003-4083-8986)
- Martina Ardito (ORCID: https://orcid.org/0000-0002-6008-9356)
- Martina Fragola (ORCID: https://orcid.org/0000-0001-9849-1001)
- Katia Mazzocco (ORCID: https://orcid.org/0000-0002-6599-5681)
- Loredana Amoroso (ORCID: https://orcid.org/0000-0003-1950-4754)
- Fabio Pastorino (ORCID: https://orcid.org/0000-0002-8312-808X)
- João Nuno Moreira (ORCID: https://orcid.org/0000-0003-3449-0522)
- Massimo Conte (ORCID: https://orcid.org/0000-0001-9405-7339)
- Mario Capasso (ORCID: https://orcid.org/0000-0003-3306-1259)
- Chiara Brignole
- Veronica Bensa (ORCID: https://orcid.org/0000-0002-4927-2731)
- Gloria E. Marino
- Rosa Musso
- Anastasiya Voronovska
- Gaetano Valerio Vellone
- Hugo Lopes-Cardoso
- Chiara Concetti
- Manuel João Soares-Gonçalves
Institutions
- Policlinico Umberto I (IT)
- Istituto Giannina Gaslini (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Biomedicine & Pharmacotherapy
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1016/j.biopha.2025.118817
- Citations
- 1
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39